Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK TRANSACTIONS (Details Narrative)

v3.22.2.2
COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Apr. 09, 2021
Jan. 31, 2022
Aug. 31, 2021
Jan. 31, 2021
Sep. 30, 2020
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2020
Aug. 09, 2021
Class of Stock [Line Items]                  
Exercise shares 2,500,000                
Offering cost                 $ 15,000,000
Stock consideration received     $ 10,720,000            
Shares Issued     2,522,387            
Common Warrants [Member]                  
Class of Stock [Line Items]                  
Warrant Exercised     2,522,387            
Third S 3 Shelf Offering [Member]                  
Class of Stock [Line Items]                  
Stock issued new, shares 19,100,000                
Proceeds from sale of equity $ 87,400,000                
Non Employee Board Member 1 [Member] | Director Letter Agreement [Member]                  
Class of Stock [Line Items]                  
Stock issued for compensation, shares               1,000  
Non Employee Board Member 2 [Member] | Director Letter Agreement [Member]                  
Class of Stock [Line Items]                  
Stock issued for compensation, shares               1,000  
Non Employee Board Member 3 [Member] | Director Letter Agreement [Member]                  
Class of Stock [Line Items]                  
Stock issued for compensation, shares               1,000  
Three Nonemployee Board Members [Member] | Director Letter Agreement [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           $ 0 $ 3,371    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares           0      
A Consultant [Member] | Medical And Scientific Advisory Board [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           $ 0 2,125    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture         333        
Officers [Member] | Compensation Agrmt 2021 [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           0 $ 11,055    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares             1,833    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture       4,400          
Officers [Member] | Compensation Agrmt 2022 [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           $ 2,750 $ 0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares           1,833      
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture   4,400              
Three Nonemployee Members 1 [Member] | Director Letter Agreement [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           $ 0 $ 4,885    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture             1,002    
Two Consultants [Member] | Consulting Agreements [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           0 $ 1,620    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares             251    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture             334    
Three Nonemployee 2 Members [Member] | Director Letter Agreement [Member] | Common Stock [Member]                  
Class of Stock [Line Items]                  
Stock based compensation expense           $ 2,278 $ 0    
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture           1,002